Recent News

By Category: Countermeasures

Protect swine herds from PED with proper biosecurity protocols

(MSUExtension) With the recent outbreak of Porcine Epidemic Diarrhea (PED) producers need to be conscious of their biosecurity protocols and methods. Strict biosecurity procedures are the first line of defense when protecting your swine herd from this disease that is new to the United States. Guidelines should be in place for cleaning and disinfection of Read More »

June 3, 2013
| Filed under North America, Agents & Toxins, Agriculture, Countermeasures, and Research
Share

Bavarian Nordic’s IMVANEX(r) Smallpox Vaccine Receives Positive Opinion From European Regulatory Authorities

(TheWallStreetJournal) Bavarian Nordic A/S (OMX:BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for IMVANEX(r) for active immunization against smallpox disease for the general adult population, including people with immunodeficiencies (people diagnosed with Read More »

June 3, 2013
| Filed under Europe, North America, Agents & Toxins, Countermeasures, International, Public Health, and Research
Share

Notable Contracts: DTRA Award to Institute for Systems Biology

(GlobalBiodefense) The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense: Institute for Systems Biology, Seattle, Wash., is being awarded a $7,665,557 cost-type contract for research into pre-symptomatic detection of post-operative Read More »

June 3, 2013
| Filed under North America, Biological Weapons, Countermeasures, Policy & Initiatives, and Research
Share

FDA Lifts Clinical Hold On PharmAthene’s SparVax(R) Anthrax Vaccine Program

(TheWallStreetJournal) PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on a proposed Phase II study of SparVax(R) , a next generation recombinant anthrax vaccine. “We are very pleased by the Read More »

May 31, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Public Health, and Research
Share

Science Academies Issue ‘G-Science’ Statements to Call World Leaders’ Attention to Global Challenges

(NationalAcademies) Science academies from around the globe issued joint statements today to call world leaders’ attention to the role science, technology, and innovation can play in the pursuit of sustainable development, and to raise their awareness of the emerging threat of drug resistance in infectious agents including tuberculosis. The “G-Science” statements are intended to inform Read More »